Pulmonary Pathophysiology and Inflammatory Response in Patients Treated With Ecmo for Severe Respiratory Failure

NCT01468142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2016-12-20

No results posted yet for this study

Summary

The purpose of this study is the observation of the course of

* the mechanics of the respiratory system
* the endexpiratory lung volume
* and the inflammatory response in patients undergoing treatment with extracorporeal life support (ECLS) due to severe refractory respiratory failure at our department.

Conditions

  • Respiratory Distress Syndrome, Adult
  • Respiratory Distress Syndrome, Child

Sponsors & Collaborators

  • Karolinska University Hospital

    lead OTHER

Principal Investigators

  • Bernhard Holzgraefe, MD · Karolinska University Hospital

  • Anders Larsson, PhD · Uppsala University, Uppsala, Sweden

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01468142 on ClinicalTrials.gov